Page last updated: 2024-09-03

gamma-hydroxyphenylbutazone and Spondylitis, Ankylosing

gamma-hydroxyphenylbutazone has been researched along with Spondylitis, Ankylosing in 1 studies

*Spondylitis, Ankylosing: A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franssen, MJ; Freij, I; Gribnau, FW; Tan, Y; Van Ginneken, CA1

Other Studies

1 other study(ies) available for gamma-hydroxyphenylbutazone and Spondylitis, Ankylosing

ArticleYear
Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
    Pharmaceutisch weekblad. Scientific edition, 1986, Aug-22, Volume: 8, Issue:4

    Topics: Chromatography, High Pressure Liquid; Humans; Oxyphenbutazone; Phenylbutazone; Specimen Handling; Spondylitis, Ankylosing

1986